Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05548803 · ClinicalTrials.gov registry record
COVID-19 Citizen Science Expansion Project
A clinical trial of Covid19, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 54,689
- Enrollment target
- 9
- Study locations
NCT05548803 is a study of Covid19 that has completed, run by University of California, San Francisco. The registered enrollment target is 54,689 participants, above the 2,121-participant average among 94 other Covid19 trials with a reported enrollment target (2478% higher). The trial reports 9 study locations across 6 states.
The verdict
NCT05548803, a study of Covid19, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 54,689 participants
- Enrollment target
- 9
- Study locations
Study Summary
COVID-19 Citizen Science (CCS), launched in March 2020, supports collaborative research on symptoms, risk factors, surveillance, biomarkers and testing for COVID-19 using the Eureka Research Platform. CCS maintains IRB approval with UCSF's IRB (UCSF IRB# 17-21879). This CCS Expansion Project, which is funded jointly by the National Institutes of Health (NIH), the Patient-Centered Outcomes Research Institute (PCORI), and the Bill and Melinda Gates Foundation, will invite patients at health systems across the US to contribute their health records data and then join the established CCS study, allows for linked analysis of CCS data and health records data, and provides the scientific rationale and plan for the project.
Conditions Studied
Study Locations (9)
New York
- NYC Health + Hospitals - New York
- New York University - New York
- Albert Einstein College of Medicine - The Bronx
California
- Sutter Health - Sacramento
- University of California, San Francisco - San Francisco
Illinois
- Advocate Aurora Health - Downers Grove
Louisiana
- Ochsner Health System - New Orleans
Texas
- Baylor Scott and White Health - Dallas
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54,689 participants |
| Start Date | 2020-11-24 |
| Est. Completion | 2024-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05548803
The ClinicalTrials.gov registry entry for NCT05548803 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54,689 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,121-participant average among 94 other Covid19 trials with a reported enrollment target (2478% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Covid19 appearing as the primary indexed condition, and to 0 interventions.
NCT05548803 reports 9 study locations spanning 6 distinct geographic areas - top geographies include New York, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT05548803 about?
NCT05548803 is a clinical study titled "COVID-19 Citizen Science Expansion Project". COVID-19 Citizen Science (CCS), launched in March 2020, supports collaborative research on symptoms, risk factors, surveillance, biomarkers and testing for COVID-19 using the Eureka Research Platform. CCS maintains IRB approval with UCSF's IRB (UCSF IRB# 17-21879). This CCS Expansion Project, which...
What is the current status of trial NCT05548803?
This trial is currently completed. The enrollment target is 54,689 participants. The study started on 2020-11-24. Estimated completion is 2024-09-01.
What conditions does trial NCT05548803 study?
This clinical trial studies the following conditions: Covid19.
Who is sponsoring clinical trial NCT05548803?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05548803 being conducted?
This trial has 9 study locations across California, Illinois, Louisiana, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
COVID-19 Survivorship Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Conversations You Want About Corona Virus Disease (COVID-19)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.